Executive summary. Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)

Enferm Infecc Microbiol Clin. 2013 Oct;31(8):528-34. doi: 10.1016/j.eimc.2013.01.014. Epub 2013 Mar 23.

Abstract

Solid organ transplant (SOT) recipients are at greater risk than the general population for complications and mortality from influenza infection. We have conducted a systematic review to assess the management and prevention of influenza infection in SOT recipients. Recommendations are provided about the procurement of organs from donors with influenza infection. We highlight the importance of the possibility of influenza infection in any SOT recipient presenting upper or lower respiratory symptoms, including pneumonia. The importance of early antiviral treatment of SOT recipients with suspected or confirmed influenza infection and the necessity of annual influenza vaccination are emphasized. The microbiological techniques for diagnosis of influenza infection are reviewed. Guidelines for the use of antiviral prophylaxis are provided. Recommendations for household contacts of SOT recipients with influenza infection and health care workers are also included. Antiviral dose adjustment guidelines are presented for cases of impaired renal function and for pediatric populations.

Keywords: Consenso; Consensus; Gripe; Influenza; Profilaxis; Prophylaxis; Transplantation; Trasplante; Tratamiento; Treatment; Vaccination; Vacunación.

Publication types

  • Consensus Development Conference
  • Practice Guideline
  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Child
  • Cross Infection / prevention & control
  • Disease Management
  • Drug Resistance, Viral
  • Humans
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / adverse effects
  • Influenza Vaccines / immunology
  • Influenza, Human / diagnosis
  • Influenza, Human / drug therapy*
  • Influenza, Human / prevention & control
  • Influenza, Human / transmission
  • Organ Transplantation*
  • Oseltamivir / administration & dosage
  • Oseltamivir / therapeutic use
  • Postoperative Complications / diagnosis
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / prevention & control
  • Superinfection / drug therapy
  • Superinfection / prevention & control
  • Zanamivir / administration & dosage
  • Zanamivir / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • Influenza Vaccines
  • Oseltamivir
  • Zanamivir